Pfizer Inc. (NYSE: PFE) reported fourth quarter 2022 earnings results today. Revenues increased 2% year-over-year to $24.3 billion but missed estimates. Reported
PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2022 financial results
Categories
Health Care
Should you buy CVS Health (CVS) stock before Q4 earnings?
CVS Health Corporation (NYSE: CVS), the largest retail pharmacy chain, is on a mission to make quality healthcare available to everyone. A
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call dated Jan. 25, 2023. Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Intuitive Surgical (ISRG) Earnings: 4Q22 Key Numbers
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported revenue of $1.66 billion for the fourth quarter of 2022, which was up 7% year-over-year. GAAP
Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results
Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net earnings decreased
Intuitive Surgical Inc (ISRG) Q4 2022 Earnings Call Transcript
Intuitive Surgical Inc (NASDAQ:ISRG) Q4 2022 Earnings Call dated Jan. 24, 2023. Corporate Participants: Brian King -- Treasurer and Head of Investor Relations Gary
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2022 earnings call dated Jan. 24, 2023 Corporate Participants: Jessica Moore -- Vice President of Investor Relations Joaquin
Earnings Infographic: Highlights of Danaher Corporation’s (DHR) Q4 results
Danaher Corporation (NYSE: DHR), a provider of industrial and medical products, reported higher sales and net profit for the fourth quarter of 2022. Fourth
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2022 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2022 earnings results today. Reported sales decreased 4.4% year-over-year to $23.7 billion. Net
Cadrenal Therapeutics downsizes IPO, looks to raise $7 million
There has been an increase in the number of pharma companies taking the IPO route to enhance their research and development activities
UnitedHealth Group Incorporated (UNH) Q4 2022 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q4 2022 earnings call dated Jan. 13, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President and
UnitedHealth Group (UNH) Earnings: 4Q22 Key Numbers
UnitedHealth Group (NYSE: UNH) reported fourth quarter 2022 earnings results today. Total revenues were $82.7 billion compared to $73.7 billion in the
Organigram Holdings Inc. (OGI) Q1 2023 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q1 2023 earnings call dated Jan. 12, 2023 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
What to expect when UnitedHealth Group (UNH) reports earnings tomorrow
Shares of UnitedHealth Group Inc. (NYSE: UNH) were down 1% on Thursday. The stock has dropped 7% year-to-date. The company is set
Tilray Inc (TLRY) Q2 2023 Earnings Call Transcript
Tilray Inc (NASDAQ: TLRY) Q2 2023 earnings call dated Jan. 09, 2023 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin Simon -- Chairman and
WBA Stock: Should you invest in Walgreens Boots Alliance ahead of earnings?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been a key contributor to the COVID-19 vaccination campaign, supported by its extensive retail network.
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent pharmacy market
Nava Health to go public with a $12Mln IPO. Here’s all you need to know
With only a few days left for 2022 to end, there aren't many initial public offerings scheduled for the rest of the
Avid Bioservices Inc (CDMO) Q2 2023 Earnings Call Transcript
Avid Bioservices Inc (NASDAQ:CDMO) Q2 2023 Earnings Call dated Dec. 07, 2022. Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President & Chief Executive
Cancer drug maker Felicitex prepares for IPO. Here’s all you need to know
Fewer companies filed for initial public offering this year, compared to 2021 when the market witnessed a record number of IPOs. With
Organigram Holdings Inc. (OGI) Q4 2022 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q4 2022 earnings call dated Nov. 29, 2022 Corporate Participants: Craig MacPhail -- Group Director, NATIONAL Capital Markets Beena